Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01192685 · ClinicalTrials.gov registry record · Early Phase 1
Transcranial Magnetic Stimulation in Major Depression With EEG and Near Infrared Spectroscopy (NIRS) Monitoring
A Early Phase 1 study, sponsored by Boston University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
NCT01192685 is a Early Phase 1 study that was terminated before completion, run by Boston University. The registered enrollment target is 2 participants.
The verdict
NCT01192685, a Early Phase 1 study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This a 12- week study (1-4 week screening, 6 weeks treatment, 2 weeks follow-up) outpatient open label clinical trial. Twenty-five subjects diagnosed with depression with a Montgomery Asberg Depression Rating Scale (MADRAS) score of 26 or higher, will be enrolled into this trial, up to fifty subjects will be consented. The primary purpose of the current study is to determine: 1) if changes in electrical activity of the brain measured by EEG in specific areas is associated with changes in the blood flow of the brain 2) Which areas of the brain show changes in electrical activity and treatment response.
Interventions
- PROCEDURE Transcranial Magnetic Stimulation (TMS)
- DEVICE near infrared spectroscopy (NIRS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01192685
The ClinicalTrials.gov registry entry for NCT01192685 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT01192685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01192685 about?
NCT01192685 is a clinical study titled "Transcranial Magnetic Stimulation in Major Depression With EEG and Near Infrared Spectroscopy (NIRS) Monitoring". This a 12- week study (1-4 week screening, 6 weeks treatment, 2 weeks follow-up) outpatient open label clinical trial. Twenty-five subjects diagnosed with depression with a Montgomery Asberg Depression Rating Scale (MADRAS) score of 26 or higher, will be enrolled into this trial, up to fifty subject...
What is the current status of trial NCT01192685?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2012-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01192685?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (PROCEDURE), near infrared spectroscopy (NIRS) (DEVICE).
Who is sponsoring clinical trial NCT01192685?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.